Phylogica Limited (Australia) Profile

AUD 0.003  11.11%

Phylogica Limited Summary

Phylogica Limited (PYC) is traded on Australian Securities Exchange in Australia. It is located in Subiaco, WA and employs 5 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 74.86 M. Phylogica Limited has 2.14 B outstanding shares. PHYLOGICA LTD has accumulated about 9.94 M in cash with (1.88 M) of positive cash flow from operations.
Check Phylogica Limited Probability Of Bankruptcy

Phylogica Limited Risk Profiles

Key Fundamentals

Phylogica Limited Against Markets

Current Ratings

Phylogica Limited 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 95% 
Equity ratings for Phylogica Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Phylogica Limited offer drug discovery research and development services utilizing proprietary Phylomer peptide libraries and screening methodologies to identify peptide drug candidates for its pharmaceutical and biotechnology partners in Australia. more
NamePhylogica Limited
CEO, Executive DirectorRichard HopkinsView All
Macroaxis Advice
InstrumentAustralia Stock View All
Business AddressSubiaco, WA
ExchangeAustralian Securities Exchange
Contact Number61 8 9489 7777
CurrencyAUD - Australian Dollar

Diversify with Phylogica Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Phylogica Limited to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Phylogica Limited Corporate Directors
Bernard Hockings Director, Ph.D
Sahm Nasseri Non-Executive Director, MBA
Rick Kendall Independent Non-Executive Director, Ph.D